ITCI
Allianz Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,100
| Closed | -$677K | – | 1870 |
|
|
2024
Q4 | $677K | Buy |
8,100
+3,100
| +62% | +$259K | ﹤0.01% | 1335 |
|
|
2024
Q3 | $366K | Buy |
+5,000
| New | +$366K | ﹤0.01% | 1491 |
|
|
2022
Q3 | – | Sell |
-12,450
| Closed | -$711K | – | 1703 |
|
|
2022
Q2 | $711K | Hold |
12,450
| – | – | ﹤0.01% | 1586 |
|
|
2022
Q1 | $762K | Hold |
12,450
| – | – | ﹤0.01% | 1658 |
|
|
2021
Q4 | $652K | Hold |
12,450
| – | – | ﹤0.01% | 1744 |
|
|
2021
Q3 | $464K | Sell |
12,450
-5,800
| -32% | -$216K | ﹤0.01% | 1804 |
|
|
2021
Q2 | $745K | Sell |
18,250
-12,635
| -41% | -$516K | ﹤0.01% | 1567 |
|
|
2021
Q1 | $1.05M | Hold |
30,885
| – | – | ﹤0.01% | 1444 |
|
|
2020
Q4 | $982K | Hold |
30,885
| – | – | ﹤0.01% | 1467 |
|
|
2020
Q3 | $793K | Buy |
30,885
+13,226
| +75% | +$340K | ﹤0.01% | 1472 |
|
|
2020
Q2 | $454K | Sell |
17,659
-18,172
| -51% | -$467K | ﹤0.01% | 1621 |
|
|
2020
Q1 | $551K | Buy |
35,831
+7,309
| +26% | +$112K | ﹤0.01% | 1612 |
|
|
2019
Q4 | $979K | Sell |
28,522
-9,042
| -24% | -$310K | ﹤0.01% | 1730 |
|
|
2019
Q3 | $281K | Buy |
37,564
+17,544
| +88% | +$131K | ﹤0.01% | 2037 |
|
|
2019
Q2 | $260K | Buy |
+20,020
| New | +$260K | ﹤0.01% | 2085 |
|
|
2016
Q2 | – | Sell |
-39,452
| Closed | -$1.1M | – | 2070 |
|
|
2016
Q1 | $1.1M | Sell |
39,452
-123,884
| -76% | -$3.44M | ﹤0.01% | 1556 |
|
|
2015
Q4 | $8.79M | Sell |
163,336
-28,902
| -15% | -$1.55M | 0.01% | 949 |
|
|
2015
Q3 | $7.7M | Buy |
+192,238
| New | +$7.7M | 0.01% | 955 |
|